XML 49 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Acquisitions (Asset Acquisitions) (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2020
May 31, 2020
Mar. 31, 2020
Sep. 30, 2019
Apr. 30, 2019
Mar. 31, 2019
Jan. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Business Acquisition [Line Items]                      
Acquired IPR&D Expense               $ 241.8 $ 25.0 $ 294.1 $ 161.9
Sitryx Therapeutics Limited                      
Business Acquisition [Line Items]                      
Acquired IPR&D Expense     $ 52.3                
AbCellera Biologics Inc.                      
Business Acquisition [Line Items]                      
Acquired IPR&D Expense   $ 25.0                  
Junshi Biosciences Co., Ltd.                      
Business Acquisition [Line Items]                      
Acquired IPR&D Expense   20.0                  
Undisclosed                      
Business Acquisition [Line Items]                      
Acquired IPR&D Expense   $ 174.8                  
Evox Therapeutics Ltd.                      
Business Acquisition [Line Items]                      
Acquired IPR&D Expense $ 22.0                    
AC Immune SA                      
Business Acquisition [Line Items]                      
Acquired IPR&D Expense       $ 30.2     $ 96.9        
ImmuNext, Inc.                      
Business Acquisition [Line Items]                      
Acquired IPR&D Expense           $ 40.0          
Avidity Biosciences, Inc.                      
Business Acquisition [Line Items]                      
Acquired IPR&D Expense         $ 25.0